The use of HEPES-buffer in the production of gallium-68 radiopharmaceuticals - time to reconsider strict pharmacopoeial limits?
Abstract HEPES (4-(2-hydroxyethyl) piperazine-1-ethanesulfonic acid) is a buffer that is used in the radiolabelling of gallium-68 compounds. The beneficial effects of HEPES on molar activity in bioconjugates have been well described. Current strict regulations on the HEPES content in radiopharmaceut...
I tiakina i:
Ngā kaituhi matua: | Jannie le Roux (Author), Janke Kleynhans (Author), Sietske Rubow (Author) |
---|---|
Hōputu: | Pukapuka |
I whakaputaina: |
SpringerOpen,
2021-04-01T00:00:00Z.
|
Ngā marau: | |
Urunga tuihono: | Connect to this object online. |
Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Ngā tūemi rite
-
New sensitive method for HEPES quantification in 68Ga-radiopharmaceuticals
mā: I. F. Antunes, me ētahi atu.
I whakaputaina: (2020) -
Cyclotron Production of Gallium-68 Radiopharmaceuticals Using the <sup>68</sup>Zn(p,n)<sup>68</sup>Ga Reaction and Their Regulatory Aspects
mā: Zarif Ashhar, me ētahi atu.
I whakaputaina: (2022) -
The determination of the radiochemical purity of Actinium-225 radiopharmaceuticals: a conundrum
mā: Janke Kleynhans, me ētahi atu.
I whakaputaina: (2022) -
Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4
mā: Simon A. M. Kaeppeli, me ētahi atu.
I whakaputaina: (2019) -
Good practices for 68Ga radiopharmaceutical production
mā: Bryce J. B. Nelson, me ētahi atu.
I whakaputaina: (2022)